Application 203501
- Type
- ANDA
- Sponsor
- GLENMARK PHARMS LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | INDOMETHACIN | INDOMETHACIN | CAPSULE, EXTENDED RELEASE;ORAL | 75MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 68462-325 | indomethacin | indomethacin | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-325 | indomethacin | indomethacin | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-325 | indomethacin | indomethacin | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-325 | indomethacin | indomethacin | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-325 | indomethacin | indomethacin | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-325 | indomethacin | indomethacin | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |